Cryolife and Regeneration Technologies Enter Into Exchange and Service Agreement

ATLANTA, Dec. 19 /PRNewswire-FirstCall/ — CryoLife, Inc., (NYSE: CRY), a biomaterials and biosurgical device company, and Regeneration Technologies Inc., (RTI) (Nasdaq: RTIX), a Florida-based processor of biologic implants, today announced that they have entered into an exchange and service agreement respecting their orthopedic and cardiovascular activities.

Source: CryoLife, Inc.